Paper1978483
Neuropharmacological and behavioural properties of remoxipride in the rat.
Ogren SO and 4 others. Acta Psychiatr Scand Suppl, 1990. Cited by 58 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Neuropharmacological and behavioural properties of remoxipride in the rat. Papers, record 1978483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1978483
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Behavior, Animal | Major topic |
| Benzamides | Major topic |
| Animals | |
| Arousal | |
| Brain | |
| Dose-Response Relationship, Drug | |
| Extrapyramidal Tracts | |
| Motor Activity | |
| Rats | |
| Receptors, Dopamine | |
| Receptors, Dopamine D2 | |
| Remoxipride |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11,607,043 | Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist. | CNS Drug Rev | 2001 | https://conductscience.org/library/papers/11607043 | PubMed |
| 8,736,614 | Adverse effects of antipsychotic agents. Do newer agents offer advantages? | Drugs | 1996 | https://conductscience.org/library/papers/8736614 | PubMed |
| 8,329,149 | Tolerability of remoxipride in the long term treatment of schizophrenia. An overview. | Drug Saf | 1993 | https://conductscience.org/library/papers/8329149 | PubMed |
| 8,217,058 | Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat. | J Neural Transm Gen Sect | 1993 | https://conductscience.org/library/papers/8217058 | PubMed |
| 8,123,230 | Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile. | J Neural Transm Gen Sect | 1993 | https://conductscience.org/library/papers/8123230 | PubMed |
| 8,099,797 | Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. | J Neural Transm Gen Sect | 1993 | https://conductscience.org/library/papers/8099797 | PubMed |
| 7,855,196 | Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile. | Psychopharmacology (Berl) | 1994 | https://conductscience.org/library/papers/7855196 | PubMed |
| 7,536,945 | Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study. | Psychopharmacology (Berl) | 1995 | https://conductscience.org/library/papers/7536945 | PubMed |
| 1,981,869 | Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia. | Drugs | 1990 | https://conductscience.org/library/papers/1981869 | PubMed |
| 1,531,593 | Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain. | J Neural Transm Gen Sect | 1992 | https://conductscience.org/library/papers/1531593 | PubMed |
| 1,450,186 | A dose-finding study with remoxipride in the acute treatment of schizophrenic patients. | J Psychiatry Neurosci | 1992 | https://conductscience.org/library/papers/1450186 | PubMed |
| 1,437,502 | Dealing with sadness, madness and hostility. New psychotropic drug remedies for the future. | Pharm Weekbl Sci | 1992 | https://conductscience.org/library/papers/1437502 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1978483
GET https://conductscience.org/api/papers/v1/1978483/authors